^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Universal Dual-target NKG2D-NKp44 CAR-T
i
Other names: Universal Dual-target NKG2D-NKp44 CAR-T, CNK-UT, Universal Chimeric Natural Killer Receptor Modified T-cells
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Yizun Biopharm, Zhejiang University
Drug class:
NKG2DL-targeted CAR-T immunotherapy, NCR2-ligand-targeted CAR-T immunotherapy
Related drugs:
